Factors influencing the effect of radioimmunotherapy on liver cancer
- 13 Downloads
Factors influencing the therapeutic effect of radioimmunotherapy with131I labeled anti-human hepa tocellular carcinoma (HCC) ferritin antibody (131I-FtAb) on thirty three patients with surgically proven unresectable HCC were studied. Multi-variable analysis with Cox’s regression model revealed that the statistically significant factors include tumor size, activity of131I administered each time and the second-look resection. Survival of patients with tumor diameter less than 10 cm was higher than that of patients with tumor diameter more than 10 cm (1-year survival; 84% versus 50%; 3-year survival; 63% versus 9%). Patients administered with 5.55×108 Bq to 9.25×108 Bq of131I-FtAb each time yielded better effect than those administered with more than 9. 25×108 Bq of131I-FtAb (1-year, survival; 86% ver-sus 55%; 3-year survival; 50% versus 18%). When tumor shrank, patients underwent second-look resection had a higher survival than those without receiving second-look resection (1-year survival; 80% versus 66%; 3-year survival; 80% versus 11%).
KeywordsRadiat Oncol Biol Phys Tumor Diameter Tocellular Carcinoma Single Variable Analysis Multiple Modality Treatment
Unable to display preview. Download preview PDF.
- 2.1986; 96:6.Google Scholar
- 3.Tang ZY, et al. Tumor imaging and targeting therapy for hepatocellular carcinoma — preliminary results of experimental and clinical studies. Chinese Med J 1986; 99:855.Google Scholar
- 4.1990; 17:405.Google Scholar
- 5.Order SE, et al.131I antiferritin, a new treatment modality in hepatoma: A radiation oncology group study. J Clin Oncol 1985; 3: 1375.Google Scholar
- 13.Cox DR, et al. Regression models and life tables. J R Statist Soc B 1972; 34:187.Google Scholar
- 15.1990; 12:2.Google Scholar
- 16.Jain RK. Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors. Cancer Research 1990(suppl); 50:814.Google Scholar
- 17.Stickney DR, et al. Enhancement of monoclonal antibody binding to melanoma with single dose irradiation or hyperthermia. Cancer Drug Del 1985; 2:225.Google Scholar
- 19.Fu KK, et al. The influence of cis-platinum administration and continuous low dose rate irradiation (CLDRI) on their combined effect on a murine squamous cell carcinoma. Int J Radiat Oncol Bio Phys 1985; 11:2119.Google Scholar
- 20.Blumenthal RD, et al. Use of hematopoietic growth factors tocontrol myelosuppression caused by radioimmunotherapy. Cancer Research 1990(suppl); 50:100.Google Scholar